GovChime
Notice ID: 6a62d2dc2d654ecf8ee0590a838317e1Combined Synopsis/Solicitation

BPA for Laboratory Reagents, Quality Control Range, patient range, and miscellaneous supplies

Archived on July 4, 2023. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
3:30 PM UTC−06:00
Posted
June 27, 2023
Notice type
Combined Synopsis/Solicitation
Set-aside
Buy Indian Set-Aside (specific to Department of Health and Human Services, Indian Health Services)
NAICS
325413: In-Vitro Diagnostic Substance Manufacturing
Agency
Department of Health and Human ServicesINDIAN HEALTH SERVICE

Notice details

Office
NAVAJO AREA INDIAN HEALTH SVC
Place of performance
Shiprock, NM, 87420
Last updated
Dec 4, 2025

Identifiers

Solicitation number
1462981
Notice ID
6a62d2dc2d654ecf8ee0590a838317e1

Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. BACKGROUND: The Navajo Area Indian Health Service, Northern Navajo Medical Center (NNMC) is requesting for offers for a contractor to deliver Laboratory Reagents, quality control range, patient range supplies which requires ice packaging (BPA) for the Laboratory Department in strict accordance to the attached Specifications. Per FAR 6.302-1(c)(2) NNMC has identified a specific brand name, but will accept brand-name or equal descriptions. SHIPPING ADDRESS: Northern Navajo Medical Center US HWY 491 North Shiprock, NM 87420 FOB: Destination EVALUATION CRITERIA: This procurement is being conducted under FAR Part 13 Simplified Acquisition Procedures. The Government reserves the right to issue a firm-fixed price single award or multiple awards to the contractor(s) whose offer represents the Lowest Price Technically Acceptable (LPTA); award will be made on the basis of the lowest evaluated price of proposals meeting or exceeding the acceptability standards for non-cost factors. SUBMITTAL PROCESS: Email your offer to the Contracting Officer for this action is: Felecia Chavez, Contract Specialist, Felecia.chavez@ihs.gov. Questions may be submitted in writing via email 2 days prior to RFQ Closing Date. To be eligible for award offeror must be registered with the System for Award Management (SAM) (https://www.sam.gov) at the time of award, and remain active through payment. To be considered for award, your offer shall include the following documents/information: Complete and sign the attached Pricing Schedule. The Government will consider competitive rates upon negotiation. Provide Quotation. Specifications: Provide your product Specifications. Provide evidence that your offered product meets the Specifications. Specifications: Provide evidence offered products were manufactured within the last 3 years or less. Delivery of Supplies: Provide evidence supplies are readily available 100% of the time and 24-hours turn-around. FAR CLAUSES: The following federal acquisition clauses will apply to the resultant contract. The full text of a clause may be accessed electronically at www.acquisition.gov 52.204-7 System Award Management (Oct 2018) 52.209-5 Certification Regarding Responsibility Matters (Aug 2020) 52.209-11 Representation by Corporations Regarding Delinquent Tax Liability or a Felony conviction under any Federal Law (Feb 2016) 52.212-4 Contract Terms and Conditions-Commercial Items (Dec 2022) 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items (Jun 2023) 52.217-8 Option to Extend Services 52.222-3 Convict Labor 52.229-3 Federal, State, and Local Taxes (Feb 2013) 52.232-33 Payment by Electronic Funds Transfer System for Award Management (Oct 2018) 52.232-40 Providing Accelerated Payments to Small Business Sub-Contractors (Mar 2023) 52.222-19 Child Labor-Cooperation with Authorities and Remedies 52.222-21 Prohibition of Segregated Facilities 52.222-26 Equal Opportunity 52.222-35 Equal Opportunity for Veterans 52.222-36 Equal Opportunity for Workers with Disabilities 52.222-37 Employment Reports on Veterans 52.222-40 Notification of Employee Rights Under the National Labor Relations Act 52.222-50 Combating Trafficking in Persons; 52.223-18, Encouraging Contractor Policies to Ban text Messaging While Driving 52.225-1 Buy American Act--Supplies 52.225-13 Restriction on Certain Foreign Purchases 52.232-33 Payment by Electronic Funds Transfer- System for Award Management 52.222-41 Service Contract Act of 1965 52.222-43 Fair Labor Standards Act and Service Contract Act Price Adjustment. The above Provisions and Clauses may be obtained via internet at http://farsite.hill.af.mil. HHSAR CLAUSES: 352.239-73 Electronic and Information Technology Accessibility Notice 352.239-74 Electronic and Information Technology Accessibility 352.232-71 Electronic Submission of Payment Requests (Feb 2022) (a) Definitions. As used in this clause Payment request means a bill, voucher, invoice, or request for contract financing payment with associated supporting documentation. The payment request must comply with the requirements identified in FAR 32.905(b), Content of Invoices and the applicable Payment clause included in this contract. (b)Except as provided in paragraph (c) of this clause, the Contractor shall submit payment requests electronically using the Department of Treasury Invoice Processing Platform (IPP) or successor system. Information regarding IPP, including IPP Customer Support contact information, is available at www.ipp.gov or any successor site. (c)The Contractor may submit payment requests using other than IPP only when the Contracting Officer authorizes alternate procedures in writing in accordance with HHS procedures. (d)If alternate payment procedures are authorized, the Contractor shall include a copy of the Contracting Officers written authorization with each payment request. The Contractor is required to submit invoices in accordance with FAR Clause 52.212-4(g) uploading into www.ipp.gov . If you require assistance registering or IPP account access, please contact the IPP Helpdesk at (866) 973-3131 (M-F 8AM to 6PM ET), or IPPCustomerSupport@fiscal.treasury.gov Department of the Treasurys IPP website that includes training materials: https://www.ipp.gov/vendors/training-vendors ATTACHMENTS: Specifications Pricing Schedule Statement of Work IHS IEE Representation Form

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:1462981
  1. Market Research
  2. Combined Synopsis
  1. Market ResearchJan 12, 2023

    BPA for Reagents and consumables

    Notice 057807cacf82404eabfbc706afc10f14 on SAM.gov

  2. 2×
    Combined SynopsisCurrentJun 27, 2023

    BPA for Laboratory Reagents, Quality Control Range, patient range, and miscellaneous supplies

    Notice 6a62d2dc2d654ecf8ee0590a838317e1 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
Please see attached Combined Synopsis/Solicitation. See attached estimated quantities and Questions and Answers.
-Combined Synopsis11/18/2026
See attached Sources Sought Notice.
-Market Research10/28/2026
This innovation from scientists at Los Alamos National Laboratory is a significant improvement on a gold standard protein purification method that gently captures and releases antibodies using mild pH changes, making antibody purification safer, more efficient, and less damaging. The Challenge: Purifying antibodies — vital tools in medicine and research — typically relies on a protein called Protein G that latches onto them. However, getting the antibodies back off this molecular “magnet” requires very acidic conditions, which can damage both the antibodies and Protein G itself. This harsh process risks ruining expensive materials and reducing the effectiveness of critical therapies and tests. Problems Solved: Researchers engineered a pH-switchable version of Protein G that uses gentle changes in acidity (pH) to control when it releases antibodies, it now binds antibodies at a mildly acidic pH and releases at a mildly basic pH — eliminating the need for harsh chemicals. This innovation protects sensitive proteins, improves efficiency, lowers costs, and opens the door for safer, greener, and more effective antibody purification in both labs and industry. Key Advantages: Gentle elution conditions: Antibodies are released at a mild pH (~8.2) instead of harsh acidic conditions (~2.7), reducing damage to both the antibodies and the protein itself. Improved antibody stability and yield: Preserving antibody structure increases reliability and effectiveness, which is especially critical for therapeutic and diagnostic use. Switchable binding mechanism: pH-sensitive histidine residues allow for a controlled "on/off" switch based on pH, improving process control and reproducibility. Cost-effective and scalable: Reduces loss of expensive antibodies and minimizes the need for post-purification repair or replacement, saving money in industrial applications. Market Applications: Biopharmaceuticals Life Sciences Research Bioprocessing and Manufacturing Tools Veterinary and Agricultural Biotech Development Status: TRL 4 US Provisional / Patent No. 10,954,275 LA-UR-25-29451 LANL Tech Partnerships: Unlock the Innovative Potential Los Alamos National Laboratory offers a wide range of cutting-edge technologies and capabilities that may provide your company with a competitive edge in the market and unlock the innovative potential that can enhance, refine, and revolutionize your products. LANL’s licensing program focuses on moving inventions developed by our researchers to commercial innovations. Patented and patent pending inventions and copyrighted software are available to existing and start-up companies through exclusive and non-exclusive licensing agreements. For specific discussions, please contact licensing@lanl.gov. Note: This is not a call for external services for the development of this technology. https://www.lanl.gov/engage/collaboration/feynman-center/partner-with-us/licensing-technology https://www.lanl.gov/engage/collaboration/feynman-center/tech-and-capability-search
-Special Notice12/05/2025
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98027Q00027. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed-price purchase order on a non-competitive basis to Integrated DNA Technologies, Inc. (IDT), 1710 Commercial Park, Coralville, IA 52241, for custom-designed ArcherDX VariantPlex Next-Generation Sequencing (NGS) target-enrichment library preparation kits. Integrated DNA Technologies, Inc. is the sole owner, manufacturer, and distributor of the proprietary ArcherDX VariantPlex Anchored Multiplex PCR (AMP) chemistry, which has been utilized by the NHLBI Hematology Branch since 2019 to perform error-correcting sequencing (ECS) and is required to maintain scientific continuity, prevent technical batch effects across longitudinal patient cohorts, and ensure compatibility with the laboratory¿s established Archer Analysis bioinformatics pipeline. All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026. (iv) The associated NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing) and the small business size standard is 1,250 employees. This requirement is not set aside for small business.
-Combined Synopsis11/05/2026
Amendment 5 is being issued to re-open the solicitation and proceed with source selection activities. Reinstate Jennifer Gartzke as the point of contact. The attached SF30 contains additional information.
-Solicitation02/15/2026

Additional Details

Solicitation Number

1462981

Archive Date

Jul 4, 2023

Office Address

WINDOW ROCK, AZ, 86515